Shanghai Longwood Biopharmaceuticals Co., Ltd.

This study tested an experimental drug called LW402 in 144 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if it safely reduces skin redness, thickness, and itching. Participants received either the drug or a placebo, and doctors measured skin impro…

This study tested a new oral medication called LW402 in 72 adults with moderate to severe rheumatoid arthritis who were already taking methotrexate. Participants received either LW402 or a placebo for 12 weeks to see if the drug could reduce joint swelling and pain. The goal was …

This early-stage trial tested the safety and tolerability of LW402 tablets in 36 healthy volunteers. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moves through the body. Since this is a Phase 1 study, the main goa…